Purpose Platinum/5-fluorouracil plus cetuximab is a standard systemic treatment for
recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) …

Patients with head and neck cancer often experience a significant decrease in their quality
of life during chemoradiotherapy (CRT) due to treatment-related pain, which is frequently …

The purpose of this paper is to update the oncologist on the correct approach to the
nutritional care of the head and neck cancer patient. Recent scientific contributions on this …

Colony-stimulating factors (CSFs) are key cytokines responsible for the production,
maturation, and mobilization of the granulocytic and macrophage lineages from the bone …

The expected incidence of squamous cell carcinoma of the head and neck (SCCHN) in the
United States in 2014 is approximately 55,070, and the predicted number of deaths from this …

Abstract Panitumumab (ABX-EGF or Vectibix), the first fully human monoclonal antibody
targeting epidermal growth factor receptor (EGFR), was approved by the Food and Drug …

Reduced nutritional state is associated with unfavourable outcomes and a lower quality of
life in patients with malignancies. Patients with active tumour disease frequently have …

Although the further modification of radiotherapy and chemotherapy within
chemoradiotherapy regimens is unlikely to offer major clinical benefits, it is likely that any …

Objective To evaluate the frequency of use, modalities and potential interest of locoregional
irradiation (LRT) in patients with upfront metastatic head and neck squamous cell carcinoma …

Simple Summary A large number of patients with head and neck squamous cell carcinoma
(HNSCC) have an advanced-stage disease (stages III to IVB) that do not respond to therapy …